Purdue Approved For OTC Biz Sale As Ch. 11 Case Drags On
A New York bankruptcy judge approved a $397 million sale of Purdue Pharma's over-the-counter drug business Tuesday, but unsecured creditors say they are concerned about the potential delay in having the...To view the full article, register now.
Already a subscriber? Click here to view full article